News

The fate of the U.S. marijuana industry is in President Donald Trump’s hands. When will President Donald Trump reclassify marijuana? is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

At least two pending job actions could have an impact on different aspects of Canada’s cannabis industry. The post Two pending possible strikes could impact cannabis sales, deliveries appeared first on StratCann.

High Tide Inc. (CVE: HITI) (NASDAQ: HITI) (FRA: 2LYA) has officially taken a significant stake in Germany’s rapidly expanding medical cannabis market. The nation’s sector has been experiencing immense growth since the implementation of its Cannabis Act in April last year. This legislation decriminalized possession of the plant for recreational use and simplified the prescription process for patients immensely. By the end of 2024, the number issued had increased by more than 1,000 per cent. The plant’s removal from the strict controls of the Narcotics Act also eliminated the need for . . .

New York’s legal marijuana agency allowed dozens of cannabis dispensaries to open too close to schools after regulators misread state law and are now pushing for a legislative fix to prevent the pot shops from having to relocate

“My position has been, and continues to be, that we should not legalize marijuana in the future.” By William Skipworth, New Hampshire Bulletin On Monday, President Donald Trump said his administration is considering reclassifying marijuana-a drug that’s been legalized for recreational use in a growing number of states over the past decade and a half. While New Hampshire Gov. Kelly Ayotte (R) said she’d respect the federal government’s decisions, she doesn’t plan to push for legalization on the state level in New Hampshire. “If federal law changes, I have to comply with federal . . .

The MAGA world is divided on how it wants President Donald Trump to come down on a proposal to federally reschedule marijuana, with key right-wing influencers sharing voicing positions on the issue after the president announced an imminent decision on Monday. While polls have repeatedly shown bipartisan support for cannabis rescheduling, as well as a broader end to prohibition, some of the most prominent Trump-allied voices are pushing back against the proposed reform. That includes people like The Daily Wire’s Matt Walsh, who claimed a social media post that “no country of potheads has . . .

Avicanna Inc. reported $6.2 million in net revenue in the three months ended June 30, 2025 (Q2 2025), gross profits of $3.1 million, and a… The post Avicanna sees increased international sales, but overall losses in Q2 2025 appeared first on StratCann.

“Watching federal agencies repeat the same failed approach with 7-OH is disappointing, but unfortunately not surprising.” By Caro Freinberg and Soren Shade, Top Tree Herbs At a recent press conference, secretary of the U.S. Department of Health and Human Services (HHS) Robert F. Kennedy Jr. endorsed the Food and Drug Administration’s (FDA) recommendation to classify 7-hydroxymitragynine (7-OH) as a federally controlled substance. Despite political promises to forge a different path, the same tired Drug War tactics were on full display. What Is 7-Hydroxymitragynine? 7-OH is one of many . . .

Terranueva Pharma Corporation has initiated a recall for one lot of its Nueva+ Le Fameux dried cannabis pre-rolls distributed in Quebec, citing an inaccurate total… The post One lot of Nueva+ Le Fameux pre-rolls recalled in Quebec due to labelling error appeared first on StratCann.

Canadian cannabis retailer High Tide is entering the German medical marijuana market through the acquisition of 51% of Remexian Pharma GmbH. Cannabis retailer High Tide entering German market via acquisition is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

As New Jersey’s first marijuana consumption lounges are opening, regulators are sharing information about where to find the sites and offering tips about how to responsibly use cannabis at the licensed businesses-including classic stoner cultural customs like “puff, puff, pass.” About a month after the New Jersey Cannabis Regulatory Commission (NJ-CRC) granted its first social consumption lounge license, regulators said “cannabis users now have legal spaces to smoke cannabis socially outside their homes.” There are currently a handful of operational consumption sites, with more . . .

Michigan cannabis sales for July fell from a year ago as they rose sequentially by 5.2%, which was up slightly on a per-day basis. At $274.7 million, sales were down 4.5% from a year earlier: The Michigan Cannabis Regulatory Agency breaks out sales by medical and adult-use, with medical sales falling 64.3% from a year ago to [ . . . ]

MediPharm Labs Corp. reported net revenue of $11.8 million in the three months ended June 30, 2025 (Q2 2025), gross profit of $3.3 million, and… The post MediPharm Labs reports revenue growth Q2 2025, driven by international sales appeared first on StratCann.

High Tide Inc. has announced that it is set to enter the German medical cannabis market by signing a definitive agreement to acquire 51% of… The post High Tide to acquire a majority stake in Remexian Pharma GmbH, marking entry into the German market appeared first on StratCann.

“I am confident that OCM and the Minnesota cannabis industry will continue to prioritize public health and safety, consumer confidence and market integrity.” By Michelle Griffith, Minnesota Reformer Minnesota Gov. Tim Walz (D) on Wednesday announced that Eric Taubel will serve as executive director of the Office of Cannabis Management. He’s been serving in the role in an interim capacity for eight months. Taubel is overseeing what’s been a sluggish cannabis market rollout after the Legislature legalized adult-use cannabis in 2023. The Office of Cannabis Management is currently issuing . . .

Founder and director of the National Cannabis Industries Assn. Aaron Smith steps down from his post a a new generation takes the helm. The post Founder steps down as NCIA looks ahead appeared first on The Leaf Online.

The transaction extends the loan’s maturity to 2030, strengthening the company’s balance sheet and positioning it for growth.

The Canadian cannabis company signed an agreement to acquire a majority stake in Remexian Pharma GmbH.

The Canadian cannabis company requested an extension to meet Nasdaq listing requirements as it considers a reverse stock split.

A federal appellate court has ruled that a New York cannabis licensing rule favoring in-state residents is unconstitutional, because it discriminates against applicants residing out-of-state. We have been tracking this case for the past couple of years – see our prior posts here and here. This decision by the Second Circuit Court of Appeals is the first to apply the Dormant Commerce Clause to adult use cannabis – and, in combination with an earlier decision involving Maine’s medical cannabis program, suggests a trend toward rejection of all protectionist state cannabis laws despite the . . .

Marijuana is associated with improvements in symptoms of female orgasmic disorder (FOD), according to a newly released scientific review. The research involved an analysis of one randomized controlled trial and 15 observational studies, using data from a total of 8,849 women. Based on the findings, study authors determined that marijuana “appears to be a promising treatment option for FOD/difficulty, with the majority of studies reviewed reporting improvements in orgasm function and satisfaction among women who use cannabis.” “This review found consistent evidence that cannabis improves . . .

High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter¹ CALGARY, AB, Aug. 14, 2025 /PRNewswire/ [ . . . ]

The President Hears “Great Things” About Medical Cannabis, But Attests Policy is Complicated.

Texas lawmakers took up a bill on Wednesday that would ban consumable hemp products containing THC. But despite the committee hearing being held, the legislation isn’t expected to advance during an ongoing special session as Democratic state lawmakers continue to deny the House a quorum to pass any measures amid a conflict over proposed redistricting. The House bill, a companion to an identical Senate-passed hemp proposal, was discussed during a lengthy meeting of the House Public Health Committee, which is able to conduct business despite the broader lack of quorum in the chamber. While the . . .

MJBowl, a bi-coastal cannabis competition, is uniting California and New York to spotlight the Most Valuable Products (MVPs) across five key categories through a collaboration between MJBizCon and social review platform Budist. New York and California square off in MJBowl cannabis competition is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs